Skip to main content
Clinical Trials/IRCT20200516047470N1
IRCT20200516047470N1RecruitingPhase 3

Evaluation of the Effectiveness of Ginkgo Biloba regimen on cognitive function in patients undergoing electroconvulsive therapy: Double blind clinical trial

Ahvaz University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • All patients admitted to the psychiatric ward of ?Ahvaz Golestan Hospital aged 18 to 60 years whose illness has been confirmed by a psychiatrist

Exclusion Criteria

  • History of epilepsy
  • History of coagulation disorders
  • History of alcohol and drug abuse
  • History of drug allergy
  • Patients who have received electroconvulsive therapy in the last 6 months before study

Investigators

Similar Trials